I Glenn Cohen

Harvard Law School.

2 papers in the library · 42 citations · publishing 2024-2026

Papers

Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement.

JAMA network open June 3, 2024 Amy L McGuire, I Glenn Cohen, Dominic Sisti et al. 41 citations

A consensus statement from a 2023 meeting of 27 experts identifies 20 points of consensus across five ethical issues for integrating psychedelic medicines into mainstream medical practice: reparations and reciprocity, equity, and respect; informed consent; professional boundaries and physical touch; personal experience; and gatekeeping. The meeting included clinicians, researchers, Indigenous groups, industry, philanthropy, veterans, retreat facilitators, training programs, and bioethicists. The statement focuses on government-approved medical use in the US and abroad, emphasizing that policymakers must address challenges ahead while acknowledging the hopeful moment.

DOI: 10.1001/jamanetworkopen.2024.14650 Full text Psychedelic therapy Psychedelic medicine Psychedelic treatment Psychedelics +15

Setting, context and the regulatory atmospheres of psychedelic medicine.

The International journal on drug policy July 1, 2026 Alex K Gearin, I Glenn Cohen, Albert Garcia-Romeu 1 citation

The revival of psychedelic medicalization is often presented as a story of scientific legitimacy and neurotherapeutic promise, but the sensitivity of psychedelics to environmental conditions has encouraged research on music, therapy, setting, and other contextual factors. This article examines how regulation actively shapes atmospheres of consumption for substances that alter affective and sensory perception. Debates over drug-centric versus therapy-centered models are situated within the broader issue of how law shapes contexts and settings of psychedelic consumption.

DOI: 10.1016/j.drugpo.2026.105327 Full text Affective atmospheres Context Prohibition Psychedelic drug policy +1